1997
DOI: 10.1016/s1079-2104(97)90010-x
|View full text |Cite
|
Sign up to set email alerts
|

5% Amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

2002
2002
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(20 citation statements)
references
References 3 publications
1
18
0
Order By: Relevance
“…All subject selection, recruitment, and experimental procedures were approved by the Khandwala et al 44 report outcomes for a large vehicle-controlled, randomized, double-blind, parallel group, multicenter clinical study involving 1335 subjects who used amlexanox oral paste (Aphthasol ® , prescription required) to treat their aphthous ulcers. It is noted those treated with this product had complete resolution of pain within three to five days in one study location and three to eight days in another.…”
Section: Methodsmentioning
confidence: 99%
“…All subject selection, recruitment, and experimental procedures were approved by the Khandwala et al 44 report outcomes for a large vehicle-controlled, randomized, double-blind, parallel group, multicenter clinical study involving 1335 subjects who used amlexanox oral paste (Aphthasol ® , prescription required) to treat their aphthous ulcers. It is noted those treated with this product had complete resolution of pain within three to five days in one study location and three to eight days in another.…”
Section: Methodsmentioning
confidence: 99%
“…One RCT of 335 patients with RAS in the US reported that 5% amlexanox significantly reduced the pain and time of healing. Other open studies have also suggested that amlexanox may result in some improvement in the signs and symptoms (Greer et al , 1993; Binnie et al , 1997; Khandwala et al , 1997).…”
Section: Other Topical Anti‐inflammatory Agentsmentioning
confidence: 97%
“…Amlexanox has been suggested to be of some benefit in the treatment of RAS. Amlexanox has anti‐allergic and anti‐inflammatory activities, but its exact mode of action in the treatment of RAS remains unknown (Khandwala et al , 1997). One RCT of 335 patients with RAS in the US reported that 5% amlexanox significantly reduced the pain and time of healing.…”
Section: Other Topical Anti‐inflammatory Agentsmentioning
confidence: 99%
“…Amlexanox The antiallergic agent amlexanox 5% (amoxanox) may significantly reduce ulcer pain and time to healing (166–169).…”
mentioning
confidence: 99%